Literature DB >> 16539283

Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus.

C Jacobi1, K Stingele, R Kretz, M Hartmann, B Storch-Hagenlocher, A Breitbart, B Wildemann.   

Abstract

Neurologic symptoms rarely occur as presenting feature of systemic lupus erythematosus (SLE). We describe a 37-year old woman who presented with several episodes of transverse myelitis and optic neuritis. Clinical, radiologic and laboratory findings were compatible with neuromyelitis optica (NMO). Seven years after disease onset clinical and laboratory findings were diagnostic for SLE. This case illustrates that NMO may represent a first manifestation of SLE for many years.

Entities:  

Mesh:

Year:  2006        PMID: 16539283     DOI: 10.1191/0961203306lu2265cr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

Review 1.  Lupoid sclerosis.

Authors:  Briele Keiserman; Luiz Fernando Garcias da Silva; Mauro W Keiserman; Carlos Alberto von Mühlen; Henrique Luiz Staub
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

Review 2.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

3.  Tumefactive demyelination associated with systemic lupus erythematosus.

Authors:  Rajesh Verma; Kamal Arya
Journal:  BMJ Case Rep       Date:  2012-05-11

4.  Aquaporin 4 molecular mimicry and implications for neuromyelitis optica.

Authors:  Radhika A Vaishnav; Ruolan Liu; Joab Chapman; Andrew M Roberts; Hong Ye; Jovan D Rebolledo-Mendez; Takeshi Tabira; Alicia H Fitzpatrick; Anat Achiron; Mark P Running; Robert P Friedland
Journal:  J Neuroimmunol       Date:  2013-05-09       Impact factor: 3.478

Review 5.  [Neuromyelitis optica].

Authors:  S Jarius; B Wildemann
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

6.  The challenge of acute non-compressive transverse myelopathies.

Authors:  Ambar Chakravarty
Journal:  Front Neurol       Date:  2010-04-23       Impact factor: 4.003

7.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 8.  Neuromyelitis Optica-AQP4: an update.

Authors:  Emilio Benavente; Sergio Paira
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.686

9.  New onset neuromyelitis optica in a young Nigerian woman with possible antiphospholipid syndrome: a case report.

Authors:  Morenikeji A Komolafe; Edward O Komolafe; Taofiki A Sunmonu; S O Olateju; C M Asaleye; Olufemi A Adesina; S A Badmus
Journal:  J Med Case Rep       Date:  2008-11-17

Review 10.  Neuromyelitis optica pathogenesis and aquaporin 4.

Authors:  David J Graber; Michael Levy; Douglas Kerr; William F Wade
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.